These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 18392330

  • 1. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
    Kirkeby A, Torup L, Bochsen L, Kjalke M, Abel K, Theilgaard-Monch K, Johansson PI, Bjørn SE, Gerwien J, Leist M.
    Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
    [Abstract] [Full Text] [Related]

  • 2. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.
    King VR, Averill SA, Hewazy D, Priestley JV, Torup L, Michael-Titus AT.
    Eur J Neurosci; 2007 Jul; 26(1):90-100. PubMed ID: 17614942
    [Abstract] [Full Text] [Related]

  • 3. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C, Pedotti R, Baggi F, Ubiali F, Gallo B, Nava S, Bigini P, Barbera S, Fumagalli E, Mennini T, Vezzani A, Rizzi M, Coleman T, Cerami A, Brines M, Ghezzi P, Bianchi R.
    J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
    [Abstract] [Full Text] [Related]

  • 4. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?
    Srisawat N, Manotham K, Eiam-Ong S, Katavetin P, Praditpornsilpa K, Eiam-Ong S.
    Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748
    [Abstract] [Full Text] [Related]

  • 5. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives.
    Villa P, van Beek J, Larsen AK, Gerwien J, Christensen S, Cerami A, Brines M, Leist M, Ghezzi P, Torup L.
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):552-63. PubMed ID: 16835629
    [Abstract] [Full Text] [Related]

  • 6. Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.
    Montero M, Poulsen FR, Noraberg J, Kirkeby A, van Beek J, Leist M, Zimmer J.
    Exp Neurol; 2007 Mar; 204(1):106-17. PubMed ID: 17157835
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotection with or without erythropoiesis; sometimes less is more.
    Torup L.
    Br J Pharmacol; 2007 Aug; 151(8):1141-2. PubMed ID: 17533424
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits.
    Lapchak PA, Kirkeby A, Zivin JA, Sager TN.
    Brain Res; 2008 Oct 31; 1238():208-14. PubMed ID: 18761001
    [Abstract] [Full Text] [Related]

  • 9. The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease.
    Thomas Tayra J, Kameda M, Yasuhara T, Agari T, Kadota T, Wang F, Kikuchi Y, Liang H, Shinko A, Wakamori T, Vcelar B, Weik R, Date I.
    Brain Res; 2013 Mar 28; 1502():55-70. PubMed ID: 23380533
    [Abstract] [Full Text] [Related]

  • 10. A neuroprotective derivative of erythropoietin that is not erythropoietic.
    Doggrell SA.
    Expert Opin Investig Drugs; 2004 Nov 28; 13(11):1517-9. PubMed ID: 15500399
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin administration increases production and reactivity of platelets in dogs.
    Wolf RF, Peng J, Friese P, Gilmore LS, Burstein SA, Dale GL.
    Thromb Haemost; 1997 Dec 28; 78(6):1505-9. PubMed ID: 9423803
    [Abstract] [Full Text] [Related]

  • 12. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Xu X, Cao Z, Cao B, Li J, Guo L, Que L, Ha T, Chen Q, Li C, Li Y.
    Surgery; 2009 Sep 28; 146(3):506-14. PubMed ID: 19715808
    [Abstract] [Full Text] [Related]

  • 13. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
    Wang Y, Zhang ZG, Rhodes K, Renzi M, Zhang RL, Kapke A, Lu M, Pool C, Heavner G, Chopp M.
    Br J Pharmacol; 2007 Aug 28; 151(8):1377-84. PubMed ID: 17603558
    [Abstract] [Full Text] [Related]

  • 14. Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury.
    Adembri C, Massagrande A, Tani A, Miranda M, Margheri M, De Gaudio R, Pellegrini-Giampietro DE.
    Crit Care Med; 2008 Mar 28; 36(3):975-8. PubMed ID: 18176311
    [Abstract] [Full Text] [Related]

  • 15. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
    Liu X, Zhu B, Zou H, Hu D, Gu Q, Liu K, Xu X.
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug 28; 253(8):1263-72. PubMed ID: 25725621
    [Abstract] [Full Text] [Related]

  • 16. High glucose levels enhance platelet activation: involvement of multiple mechanisms.
    Sudic D, Razmara M, Forslund M, Ji Q, Hjemdahl P, Li N.
    Br J Haematol; 2006 May 28; 133(3):315-22. PubMed ID: 16643434
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
    Kamruzzaman SM, Endale M, Oh WJ, Park SC, Kim KS, Hong JH, Kwak YS, Yun BS, Rhee MH.
    J Ethnopharmacol; 2010 Aug 09; 130(3):614-20. PubMed ID: 20558266
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of erythropoietin and its carbamylated derivative on behaviour and hippocampal neurogenesis in mice.
    Leconte C, Bihel E, Lepelletier FX, Bouët V, Saulnier R, Petit E, Boulouard M, Bernaudin M, Schumann-Bard P.
    Neuropharmacology; 2011 Aug 09; 60(2-3):354-64. PubMed ID: 20932982
    [Abstract] [Full Text] [Related]

  • 19. Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties.
    Moon C, Krawczyk M, Paik D, Coleman T, Brines M, Juhaszova M, Sollott SJ, Lakatta EG, Talan MI.
    J Pharmacol Exp Ther; 2006 Mar 09; 316(3):999-1005. PubMed ID: 16306273
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia.
    Liu W, Shen Y, Plane JM, Pleasure DE, Deng W.
    Exp Neurol; 2011 Aug 09; 230(2):227-39. PubMed ID: 21596035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.